BY RENE DEICHGRÆBER, TRANSLATED BY DANIEL PEDERSEN
The Novo Nordisk Foundation is granting USD 46.1m (DKK 290m) to the new international research center, while ramping up its global activities.
The goal is to expand the Danish life science ecosystem by creating global access to leading scientists, technologies and training programs. This is why the commercial foundation, with a net worth of USD 71.5bn (DKK 450bn), plans to establish several similar centers in the coming years, says CEO at the Novo Nordisk Foundation Mads Krogsgaard Thomsen.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Germany orders 40,000 monkeypox vaccines from Bavarian Nordic
The German Minister for Health has revealed that the German state has ordered vaccines from Bavarian Nordic, as the country reports 5 cases of monkeypox.
New head of research at Astellas Gene Therapies: "Choosing the right indications is extra important"
Morten Søgaard is leaving Pfizer to join Astellas, where he will be in charge of 100 employees. Going from one of the world largest pharmaceutical firms to a considerably smaller one will be a challenge, he says.
Rumored purchase of GN Group could mean divestment of hearing aid division, says media
Inside Business has learned that a number of buyers might be looking to buy GN Store Nord stock while it’s cheap, with the plan to sell one division, GN Hearing, while keeping Audio.
EMA publishes new plan to support antibiotic development
Drug-resistant bacteria kill hundreds of thousands of people every year, and national regulatory forces across the world are now coming together to ensure a uniform approach to clinical trials for antibiotics.
Carb-X secures USD 370m in fight against antibiotic resistance
International antibiotic alliance Carb-X has received commitments of up to USD 370m to accelerate the development of new antibiotics to combat a future shortage. The news is welcomed by several players on the AMR field.
Director for innovative pre-clinical testing unit 
Analytical Senior Scientist 
Director of Toxicology 
Strategic Procurement Manager, Direct Spend (Category Manager) 
Nordic Medical Affairs Manager 
Key Account Manager, Europe and Asia 
Client Talent Acquisition Specialist 
Account Manager 
Senior IT Network Engineer 
Senior Chemical Safety Advisor 
Project Manager & Scrum Master 
Senior Project Manager (GMP - Life Science) 
Production Director 
Clinical Project Manager 
System Sales Development Consultant - Investment Projects, Merck Millipore 
(Senior) Drug Substance Specialist